{"entity":{"type":"insider","cik":"0001553071","url":"/insider/0001553071","json_url":"/insider/0001553071.json","name":"Frazier Healthcare VII, L.P.","name_source":"as-filed","also_issuer":false,"cross_url":null},"coverage_statement":{"n_transactions":6,"n_filings":3,"first":"2017-01-31","last":"2021-07-20","span_basis":"filed_date"},"name_variants":[{"name":"Frazier Healthcare VII, L.P.","source":"filing","n_filings":3,"first_seen":"2017-01-31","last_seen":"2021-07-20"}],"transactions":[{"id":4699498,"accession":"0001567619-21-013730","txn_seq":8,"anchor":"line-8","filing_url":"/filing/0001567619-21-013730","line_url":"/filing/0001567619-21-013730","is_derivative":false,"issuer_cik":"0001365617","issuer_name":"Imago BioSciences, Inc.","issuer_ticker":"IMGO","issuer_name_source":null,"issuer_url":"/issuer/0001365617","owner_cik":null,"owner_name":"FHM VII, L.L.C.; Heron Patrick J; FHM VII, L.P.; Frazier Healthcare VII, L.P.; Frazier Healthcare VII-A, L.P.","owner_display_name":"FHM VII, L.L.C.","owner_url":null,"role":"Director, Ten percent owner","role_mark":null,"role_mark_label":"Not attributed","role_mark_generic":"Not stated","n_reporting_owners":5,"other_reporting_owners":4,"officer_title":null,"security_title":"Common Stock","transaction_code":"P","transaction_label":"Open-market purchase","open_market":true,"acquired_disposed":"A","direction_word":"acquired","shares":187500.0,"shares_display":"187,500","price_per_share":16.0,"price_display":"16.00","price_state":"stated","total_value":3000000.0,"total_display":"3,000,000.00","total_whole":"3,000,000","shares_owned_after":145918.0,"shares_owned_after_display":"145,918","ownership_form":"I","is_10b5_1":null,"transaction_date":"2021-07-20","filed_date":"2021-07-20","scope":"insider","n_lines":2},{"id":6760270,"accession":"0001209191-18-034197","txn_seq":8,"anchor":"line-8","filing_url":"/filing/0001209191-18-034197","line_url":"/filing/0001209191-18-034197","is_derivative":false,"issuer_cik":"0001365617","issuer_name":"Iterum Therapeutics plc","issuer_ticker":"ITRM","issuer_name_source":null,"issuer_url":"/issuer/0001365617","owner_cik":null,"owner_name":"FHM VII, L.L.C.; Frazier Healthcare VII-A, L.P.; Heron Patrick J; FHM VII, L.P.; Frazier Healthcare VII, L.P.","owner_display_name":"FHM VII, L.L.C.","owner_url":null,"role":"Director, Ten percent owner","role_mark":null,"role_mark_label":"Not attributed","role_mark_generic":"Not stated","n_reporting_owners":5,"other_reporting_owners":4,"officer_title":null,"security_title":"Ordinary Shares","transaction_code":"P","transaction_label":"Open-market purchase","open_market":true,"acquired_disposed":"A","direction_word":"acquired","shares":456099.0,"shares_display":"456,099","price_per_share":13.0,"price_display":"13.00","price_state":"stated","total_value":5929287.0,"total_display":"5,929,287.00","total_whole":"5,929,287","shares_owned_after":1197161.0,"shares_owned_after_display":"1,197,161","ownership_form":"I","is_10b5_1":null,"transaction_date":"2018-05-30","filed_date":"2018-05-30","scope":"insider","n_lines":2},{"id":5312559,"accession":"0001012975-17-000071","txn_seq":7,"anchor":"line-7","filing_url":"/filing/0001012975-17-000071","line_url":"/filing/0001012975-17-000071","is_derivative":false,"issuer_cik":"0001018534","issuer_name":"ANAPTYSBIO INC","issuer_ticker":"ANAB","issuer_name_source":null,"issuer_url":"/issuer/0001018534","owner_cik":null,"owner_name":"Heron Patrick J; FHM VII, L.P.; Every Nathan R; Naini Nader J; Frazier Healthcare VII-A, L.P.; Frazier Healthcare VII, L.P.; FHM VII, L.L.C.; FRAZIER ALAN D","owner_display_name":"Heron Patrick J","owner_url":null,"role":"Ten percent owner","role_mark":null,"role_mark_label":"Not attributed","role_mark_generic":"Not stated","n_reporting_owners":8,"other_reporting_owners":7,"officer_title":null,"security_title":"Common Stock","transaction_code":"P","transaction_label":"Open-market purchase","open_market":true,"acquired_disposed":"A","direction_word":"acquired","shares":400000.0,"shares_display":"400,000","price_per_share":15.0,"price_display":"15.00","price_state":"stated","total_value":6000000.0,"total_display":"6,000,000.00","total_whole":"6,000,000","shares_owned_after":311291.0,"shares_owned_after_display":"311,291","ownership_form":"D","is_10b5_1":null,"transaction_date":"2017-01-31","filed_date":"2017-01-31","scope":"insider","n_lines":2}],"collapsed":true,"next_cursor":null,"ledger_fault":false,"count":{"value":0,"kind":"exact"},"open_market_only":false,"composition":{"kind":"exact","rows":[{"code":"P","label":"Open-market purchase","n":0,"open_market":true},{"code":"S","label":"Open-market sale","n":0,"open_market":true},{"code":"M","label":"Option exercise","n":0,"open_market":false},{"code":"A","label":"Grant or award","n":0,"open_market":false},{"code":"F","label":"Tax withholding","n":0,"open_market":false},{"code":"D","label":"Disposition to the issuer","n":0,"open_market":false},{"code":"X","label":"In-the-money option exercise","n":0,"open_market":false}],"total":0},"affiliations":[{"type":"issuer","type_label":"ISSUER","cik":"0001623715","name":"Imago BioSciences, Inc.","url":"/issuer/0001623715","role":"Ten percent owner","n_filings":1,"first_seen":"2021-07-20","last_seen":"2021-07-20"},{"type":"issuer","type_label":"ISSUER","cik":"0001659323","name":"Iterum Therapeutics plc","url":"/issuer/0001659323","role":"Ten percent owner","n_filings":1,"first_seen":"2018-05-30","last_seen":"2018-05-30"},{"type":"issuer","type_label":"ISSUER","cik":"0001370053","name":"ANAPTYSBIO INC","url":"/issuer/0001370053","role":"Ten percent owner","n_filings":1,"first_seen":"2017-01-31","last_seen":"2017-01-31"}],"order_statement":"Newest transaction date first, id breaking the tie.","canonical_url":"https://ebomi.com/insider/0001553071","retrieved_at":"2026-08-22T23:54:13+00:00","coverage":{"filings":1506293,"transactions":4290787,"issuers":28597,"insiders":152303,"first_filed_date":"2003-06-30","last_filed_date":"2026-08-21","last_ingest":"2026-08-22T05:23:40.159918+00:00","counts_are":{"filings":"estimate","transactions":"estimate","issuers":"estimate","insiders":"estimate"},"source":"SEC EDGAR Form 4 filings, parsed by ebomi","fault":false},"license":{"underlying_records":"US SEC filings are public records of the United States government and are not subject to copyright. The transactional facts in them are not ours to license.","this_presentation":"The parsing, normalisation, curation, and presentation are ebomi's own work.","grant":"undecided","grant_note":"The open licence for ebomi's own layer is an open owner decision (SPEC-20260731T1159Z open question 3: CC BY 4.0 or CC0 with a citation request). Until it is taken, no grant is asserted here.","citation_request":"Balogh, A. Insider trading. Scientific Data 10, 237 (2023)","url":"https://ebomi.com/license"},"fair_use":{"policy":"These JSON endpoints are open and unauthenticated. Please read them at a human pace, identify your client in the User-Agent header, and use the published dataset for bulk work rather than crawling page by page.","bulk_alternative":"doi:10.1038/s41597-023-02147-6"}}